Stakeholder Engagement
Primary Research: Payer Value Assessments
MKTXS provides clients with access to intelligent and strategic foresight necessary to maximize an asset’s value across multiple healthcare markets (reimbursed, mixed, self-pay, etc.) through primary payer research (1-1 interviews, dyads/triads/ advisory boards or surveys):
- Engage in post-launch studies to maintain (in cases of generic entry) value and access
- Further enhance (maximize within patent protection) payer perceived value through market shaping and evidence generation recommendations
MKTXS is well experienced in conducting primary research:
- Our vast network of payers and payer influencers has allowed us to address a broad scope of business questions within a rapid timeframe
- Our insights have provided clients with specific action steps to appropriately guide commercial development, in-licensing decisions, P&R negotiation planning, launch sequencing, and various payer communications and objection handling
MKTXS UNIQUE expertise in Stakeholder Assessment
Expert moderator, with 17+ years of independent ownership in the consulting industry
Vast stakeholder network worldwide with relevant payer archetypes
30+ years of experience in global pharmaceutical pricing & market access
We can effectively map the network of US influencers impacting access
US Payers:
In the US, we are able to conduct qualitative and quantitative research and are able to access
Third Party Payers
• MCO
• Integrated Systems
• CAC (risk holders)
Third Party Managers
• Medicaid Tx carve outs
• Managed Medicaid
• Managed Medicare
• PBMs
Medicaid
VA
Policy Makers
• Guidelines
• HTA
• Quality Controllers
Influencers:
• KOLS
• Advocacy
• Disease management
• Employers
• Patients
• Formulary decision makers
• Guideline developers/enforcers
• Public consultants
• Decision making intermediaries, e.g. PBMs
